Infective endocarditis caused by Acinetobacter (A.) baumannii is a rare but severe complication that affects seriously ill, hospitalized patients undergoing invasive procedures. It is associated with an increased mortality rate than that of endocarditis due to the HACEK group (Haemophilus species, Aggregatibacter actinomycetemcomitans, Cardiobacterium hominis, Eikenella corrodens, Kingella kingae) gram-negative bacteria. We report a case of a 54-year-old woman who was diagnosed with infective endocarditis caused by A. baumannii three days following her admission to the intensive unit care (ICU). The diagnosis was made on the basis of repeated blood cultures and transthoracic echocardiography, which revealed mobile vegetation attached to the mitral valve. In spite of aggressive therapeutic regimens, outcomes were poor and the patient died. This report underlines the severe nature of A. baumannii infections, which are still associated with a prolonged hospital stay, and increased morbidity, mortality, and medical costs.
Acute limb ischemia (ALI) is an abrupt interruption of limb blood flow due to acute occlusion of the peripheral artery. Its concomitant occurrence with myocardial infarction (MI) constitutes a rare but serious clinical situation that worsens the functional prognosis of the affected limb or leads to the death of the patient.
We report a case of an 87-year-old male patient who was diagnosed with acute left lower limb ischemia concomitant with MI. The diagnosis was based on clinical, electrical data and arterial angiography scan of limb findings. Thanks to urgent myocardial revascularization associated with that of the lower limb, curative heparin therapy, and armed clinical surveillance, the evolution was favorable.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.